Drugs / Pneumococcal Conjugate Vaccine, Heptavalent
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00000829 | ? → Oct 1999 | HIV infectious disease, pneumococcal infection | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00013871 | ? → Nov 2004 | HIV infectious disease, hepatitis B virus infection, measles, pertussis +1 | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00031070 Background | ? → Dec 2006 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumococcal Conjugate Vaccine, Heptavalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00031070 ↗ |
| Modality | Vaccine | “A heptavalent pneumococcal conjugate vaccine has been developed” NCT00000829 ↗ |
| Route | Intramuscular | “Patients receiving intramuscular heptavalent pneumococcal conjugate vaccine” NCT00000829 ↗ |